Immunization of man against sporozite-induced falciparum malaria.
about
Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyondMalaria parasite pre-erythrocytic stage infection: gliding and hidingA review of malaria vaccine clinical projects based on the WHO rainbow tableNovel approaches to identify protective malaria vaccine candidatesMultistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaquesStructure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidateAcquired immunity to malariaMolecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donorImmunoregulation in human malaria: the challenge of understanding asymptomatic infectionMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsVaccines against malariaVaccines for malaria: how close are we?In vivo CD8+ T cell dynamics in the liver of Plasmodium yoelii immunized and infected miceIdentification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite ProteinProtective immunity to liver-stage malariaThe March Toward Malaria VaccinesTranscriptional analysis of the pre-erythrocytic stages of the rodent malaria parasite, Plasmodium yoeliiComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensIdentification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profilingPreerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by designA virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial.Conserved protective mechanisms in radiation and genetically attenuated uis3(-) and uis4(-) Plasmodium sporozoitesCharacterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responsesWhy functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.Malaria parasite development in the mosquito and infection of the mammalian host.Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria VaccineThe Jeremiah Metzger lecture: new additions to the toolbox for global malaria eradication.Strategies for designing and monitoring malaria vaccines targeting diverse antigensInfectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trialsgammadelta T cells are a component of early immunity against preerythrocytic malaria parasites.Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimenAdvances and challenges in malaria vaccine development.Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoitesA full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.In vivo testing of subunit vaccines against malaria sporozoites using a rodent system.
P2860
Q20905953-6D8200F5-A409-4249-B6E3-EA6B878AE42FQ21032491-F6628B0A-E18B-4831-99D0-2890439B0C3DQ21034112-F2744803-F39D-4566-89EF-FFAC799B555FQ21131082-3915C85A-8B7A-4D59-866D-D232A0AB97B6Q24548638-F6FD05E2-FD1A-4713-BE20-D4963D738076Q24648408-376961DF-B2AA-4A44-838F-701B737A35ECQ24651173-CAC5D0B1-197A-481D-8B18-8E205EBA9718Q24798369-E7FCC92A-6F92-495A-8E0A-FFFDE4293C53Q26775212-C31D2194-AAA9-4168-9BC1-0B018FC83EF8Q26781372-FB9E1FAD-6FFA-4548-9E82-0F46B6E575DFQ26995079-D761070F-06E0-4BC1-B8BB-7F9F3B286D6FQ27024344-2893D129-869D-4F13-8DB7-A271984A693FQ27310073-864CAEFF-EDF0-477C-B41A-75F5EFD221C5Q27973488-2687EC3C-B7F8-4B53-8D98-2CF9AEE72DBEQ28068626-6BD246B9-7DC5-4245-BBA2-CBA96CE27FD9Q28084325-5F3CD1B9-5F33-418D-80FD-C57D90E2CABEQ28473729-14AD1C70-DEE8-4E9B-A256-AB53EE0D8F29Q28551311-DE7E9679-5E98-496A-8209-311AAFF18EC0Q28704543-3C0D3097-488E-4AF3-9B71-63435C83C6CFQ30043830-9E116423-5B40-4839-BA25-FD4BAB2EB3BAQ33308737-5677951D-FEF9-4949-A0F0-5A33C2D5771AQ33408831-B9959C9C-DE50-4617-BE71-B968D07B7B1FQ33512110-7DD4319D-9AE7-4CC2-9416-E7D10202EBB6Q33557760-AAB28249-C53F-4FCC-8C0E-C59CFCD683AAQ33587443-CF977D85-65D4-4973-B8B5-40AC14788C59Q33738231-3B7906AD-CE86-4992-9B57-53988BA0025AQ33744460-366A0878-253C-4DE6-B6B8-CCAFC4DB3400Q33957657-E6D8A1B3-7DC4-474D-AA7F-CE096B21A23EQ33959038-1B3AFA35-0E27-45C7-9829-AC49A7F42984Q34001568-B4D941E9-B1C2-40F6-954F-F002783D9BEBQ34003993-51217FBF-CAAC-4855-88F3-B06F4C1513C1Q34129094-CAC55249-65B6-46E9-9340-F07914E35C29Q34145333-72297582-15F0-458D-AF81-ECC1003B135FQ34162092-DDAE5FEA-37A7-4AF5-B397-575EE1A062D3Q34204920-EDCEAD73-FEF8-4EDD-8CDF-AA64989D2920Q34232909-81F8D80E-B696-436E-890E-5FB3110BE7A4Q34249872-020B9585-06E9-409A-BF3A-900E2DBA7F9FQ34260750-2DF84B4A-5FD0-4533-BD17-99F1281D838BQ34289823-3E38F567-0111-41EE-B3C6-7F234841DD4DQ34373653-395FD5C4-5DF2-4EE5-89F6-9F4BD67AA7FE
P2860
Immunization of man against sporozite-induced falciparum malaria.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh-hant
name
Immunization of man against sporozite-induced falciparum malaria.
@en
Immunization of man against sporozite-induced falciparum malaria.
@nl
type
label
Immunization of man against sporozite-induced falciparum malaria.
@en
Immunization of man against sporozite-induced falciparum malaria.
@nl
prefLabel
Immunization of man against sporozite-induced falciparum malaria.
@en
Immunization of man against sporozite-induced falciparum malaria.
@nl
P2093
P921
P1476
Immunization of man against sporozite-induced falciparum malaria.
@en
P2093
P304
P407
P577
1973-09-01T00:00:00Z